Thermo Fisher releases GeneArt products in China
Asia Pacific is predicted to be the fastest growing market for synthetic biology from 2018 to 2025, driving increased demand for genome editing and gene synthesis technologies. To fulfill researchers’ needs, Thermo Fisher Scientific Inc., the world leader in serving science, is now offering its portfolio of Invitrogen GeneArt products and services in China.
According to the company, in response to the growing customer demand for more efficient, reliable gene synthesis and genome editing technologies, the line of GeneArt products has been launched in China. GeneArt products will not only enable the customers to continually enhance the understanding of how biology works, it will also help them accelerate the path from planning experiments to executing them in the lab. With the Invitrogen GeneArt product line, researchers in China now have access to: Invitrogen GeneArt Gene Synthesis Service, GeneArt Strings DNA Fragments and Libraries, and GeneArt Genome Editing Tools.